Aquestive Therapeutics, Inc. (AQST) Gross profit 2019–2025
Aquestive Therapeutics, Inc. (AQST) annual gross profit history from SEC filings — each fiscal year as reported.
$26.0MFY2025 · since FY2019: $32.2M → $26.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $26.0M | -34.5% |
| FY2024 | $39.7M | +33.4% |
| FY2023 | $29.8M | +5.2% |
| FY2022 | $28.3M | — |
| FY2020 | $32.9M | +2.0% |
| FY2019 | $32.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice